Evidence map›Paper›PMID 39374312›Full record

ReviewJournal of applied clinical medical physics2024

A review of deep learning approaches for multimodal image segmentation of liver cancer.

Chaopeng Wu, Qiyao Chen, Haoyu Wang, Yu Guan, Zhangyang Mian, Cong Huang, Changli Ruan, Qibin Song, Hao Jiang, Jinghui Pan and 1 more

Abstract readReview
In one paragraph

Review in Journal of applied clinical medical physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chaopeng WuDepartment of Radiation Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.ORCID https://orcid.org/0009-0000-3762-6443
Qiyao ChenDepartment of Radiation Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.
Haoyu WangDepartment of Radiation Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.
Yu GuanDepartment of Radiation Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.
Zhangyang MianDepartment of Radiation Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.
Cong HuangDepartment of Radiation Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.
Changli RuanDepartment of Radiation Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.
Qibin SongDepartment of Radiation Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.
Hao JiangSchool of Electronic Information, Wuhan University, Wuhan, Hubei, China.
Jinghui PanDepartment of Radiation Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.ORCID https://orcid.org/0000-0002-8283-4396
Xiangpan LiDepartment of Radiation Oncology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.

Funding

Cisco hausen Cancer Research Foundation Y-HS202101-0079Health and Family Planning Commission of Hubei Province WJ2017M027Interdisciplinary Innovative Talents Foundation from Renmin Hospital of Wuhan University JCRCWL-2022-003Key Research and Development Project of Hubei Province's Technical Innovation Plan 2023BCB020Natural Science Foundation of Hubei Province 2019CFB721Research Foundation on Cutting-edge Cancer Supportive Care cphcf-2022-146
6 · The paper itself

Abstract

This review examines the recent developments in deep learning (DL) techniques applied to multimodal fusion image segmentation for liver cancer. Hepatocellular carcinoma is a highly dangerous malignant tumor that requires accurate image segmentation for effective treatment and disease monitoring. Multimodal image fusion has the potential to offer more comprehensive information and more precise segmentation, and DL techniques have achieved remarkable progress in this domain. This paper starts with an introduction to liver cancer, then explains the preprocessing and fusion methods for multimodal images, then explores the application of DL methods in this area. Various DL architectures such as convolutional neural networks (CNN) and U-Net are discussed and their benefits in multimodal image fusion segmentation. Furthermore, various evaluation metrics and datasets currently used to measure the performance of segmentation models are reviewed. While reviewing the progress, the challenges of current research, such as data imbalance, model generalization, and model interpretability, are emphasized and future research directions are suggested. The application of DL in multimodal image segmentation for liver cancer is transforming the field of medical imaging and is expected to further enhance the accuracy and efficiency of clinical decision making. This review provides useful insights and guidance for medical practitioners.

Indexed as

Deep LearningImage Processing, Computer-AssistedLiver NeoplasmsMultimodal ImagingAlgorithmsCarcinoma, HepatocellularHumansNeural Networks, Computerdeep learningliver cancermultimodal fusion technologysegmentation

Identifiers

PMID39374312
PMCPMC11633801

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.